U.S. Markets close in 11 mins

A Look at Incyte’s Valuation on August 22

Mike Benson
A Look at Incyte’s Valuation on August 22

Incyte (INCY), a biopharmaceutical company, is focused on the discovery, development, and commercialization of various products to cater to unmet medical needs in oncology and the treatment of other diseases.